|
|
CALL
|
$48,000
|
11.4K
|
Q2 2025
Reduced 70.31%
|
|
|
|
PUT
|
$51,000
|
12K
|
Q2 2025
Reduced 60.0%
|
|
|
|
CALL
|
$7,000
|
500
|
Q2 2025
Reduced 96.86%
|
|
|
|
PUT
|
$131,000
|
8.8K
|
Q2 2025
Added 46.67%
|
|
Natural Gas Svcs Group Inc
|
CALL
|
$2.83 Million
|
110K
|
Q2 2025
Added 296.39%
|
|
|
|
CALL
|
$7,000
|
100
|
Q2 2025
New holding
|
|
|
|
PUT
|
$294,000
|
4.2K
|
Q2 2025
New holding
|
|
Natural Health Trends Corp
|
PUT
|
$2,000
|
500
|
Q2 2025
Added 25.0%
|
|
|
|
CALL
|
$24,000
|
600
|
Q2 2025
Reduced 94.23%
|
|
|
|
PUT
|
$4.27 Million
|
106K
|
Q2 2025
Reduced 6.61%
|
|
|
|
CALL
|
$7.8 Million
|
46.2K
|
Q2 2025
Reduced 73.14%
|
|
|
|
PUT
|
$2.15 Million
|
12.7K
|
Q2 2025
Reduced 83.18%
|
|
|
|
CALL
|
$5,000
|
7.6K
|
Q2 2025
Reduced 22.45%
|
|
|
|
PUT
|
$1,000
|
1.3K
|
Q2 2025
New holding
|
|
|
|
CALL
|
$12,000
|
3.6K
|
Q2 2025
Reduced 69.75%
|
|
|
|
PUT
|
$170,000
|
50.6K
|
Q2 2025
Added 468.54%
|
|
|
|
CALL
|
$3.45 Million
|
134K
|
Q2 2025
New holding
|
|
|
|
PUT
|
$5.37 Million
|
208K
|
Q2 2025
New holding
|
|
|
|
CALL
|
$23,000
|
13.9K
|
Q2 2025
Added 90.41%
|
|
|
|
PUT
|
$26,000
|
15.8K
|
Q2 2025
Reduced 25.47%
|
|
Net Lease Office Properties
|
CALL
|
$1.11 Million
|
34K
|
Q2 2025
Added 23.19%
|
|
Net Lease Office Properties
|
PUT
|
$16,000
|
500
|
Q2 2025
New holding
|
|
Annaly Capital Management In
|
CALL
|
$4.7 Million
|
250K
|
Q2 2025
Added 59.32%
|
|
Annaly Capital Management In
|
PUT
|
$4.66 Million
|
248K
|
Q2 2025
Added 48.95%
|
|
|
|
CALL
|
$992,000
|
65.6K
|
Q2 2025
New holding
|
|
|
|
PUT
|
$742,000
|
49.1K
|
Q2 2025
New holding
|
|
|
|
PUT
|
$21,000
|
2K
|
Q2 2025
Added 900.0%
|
|
|
|
CALL
|
$122,000
|
2.9K
|
Q2 2025
Added 1350.0%
|
|
|
|
PUT
|
$8,000
|
200
|
Q2 2025
Added 100.0%
|
|
Navios Maritime Partners L P
|
CALL
|
$1.2 Million
|
31.8K
|
Q2 2025
Reduced 37.52%
|
|
Navios Maritime Partners L P
|
PUT
|
$821,000
|
21.8K
|
Q2 2025
Added 136.96%
|
|
|
|
CALL
|
$28,000
|
4.4K
|
Q2 2025
New holding
|
|
|
|
PUT
|
$12,000
|
1.9K
|
Q2 2025
Added 171.43%
|
|
Neumora Therapeutics Inc.
|
CALL
|
$27,000
|
37.8K
|
Q2 2025
Reduced 32.01%
|
|
Neumora Therapeutics Inc.
|
PUT
|
$0
|
100
|
Q2 2025
Reduced 80.0%
|
|
|
|
CALL
|
$38,000
|
3.2K
|
Q2 2025
New holding
|
|
|
|
PUT
|
$1,000
|
100
|
Q2 2025
Reduced 50.0%
|
|
Neuroone Med Technologies CO
|
CALL
|
$1,000
|
2.5K
|
Q2 2025
Added 25.0%
|
|
|
|
CALL
|
$8.59 Million
|
593K
|
Q2 2025
Reduced 1.8%
|
|
|
|
PUT
|
$4.48 Million
|
295K
|
Q2 2025
Added 421.24%
|
|
|
|
CALL
|
$8,000
|
4.2K
|
Q2 2025
New holding
|
|
|
|
CALL
|
$87,000
|
53.9K
|
Q2 2025
Reduced 63.31%
|
|
|
|
PUT
|
$1.3 Million
|
800K
|
Q2 2025
Reduced 37.84%
|
|
|
|
CALL
|
$8.09 Million
|
235K
|
Q2 2025
Added 8.01%
|
|
|
|
PUT
|
$2.77 Million
|
80.4K
|
Q2 2025
Added 33.78%
|
|
|
|
CALL
|
$738,000
|
17.1K
|
Q2 2025
Added 24.82%
|
|
|
|
PUT
|
$103,000
|
2.4K
|
Q2 2025
Reduced 60.66%
|
|
|
|
CALL
|
$1.46 Million
|
282K
|
Q2 2025
Reduced 6.72%
|
|
|
|
PUT
|
$997,000
|
193K
|
Q2 2025
Reduced 21.83%
|
|
|
|
CALL
|
$3,000
|
2.7K
|
Q2 2025
Reduced 85.25%
|
|
